NCT05611541

Brief Summary

This research is a randomized controlled experimental study to evaluate the effects of PMR application based on HBM in terms of blood sugar and anxiety levels in women with GDM. 34 pregnant women who applied PMR formed the "intervention group" and 34 pregnant women who did not practice PMR formed the "control group". The intervention group received "Progressive Muscle Relaxation Training". It was determined that there was a statistically significant difference between the last follow-up state anxiety score averages, and the intermediate and final follow-up trait anxiety scores between the intervention and control groups. It was determined that PMR provided a decrease in psychological anxiety levels in pregnant women with GDM, and did not have a positive effect on physiologically fasting, 1 hour postprandial and 2 hour postprandial blood glucose levels. PMR training prepared based on HBM is a method that nurses can perform independently to ensure the psychological well-being of pregnant women with GDM.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2018

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2020

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2021

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

September 12, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 10, 2022

Completed
Last Updated

November 10, 2022

Status Verified

November 1, 2022

Enrollment Period

2.1 years

First QC Date

September 12, 2022

Last Update Submit

November 3, 2022

Conditions

Keywords

gestational diabetesHealth Belief ModelProgressive Relaxation ExerciseAnxietyBlood Sugar

Outcome Measures

Primary Outcomes (12)

  • Anxiety Level

    State-Trait Anxiety Inventory is a Likert-type scale consisting of 20 questions that measures state and trait anxiety levels separately. There are two kinds of expressions in the scales. These are called direct and reverse expressions. Direct expressions, negative emotions; reversed expressions express positive emotions. The scores obtained from both scales separately vary between 20 and 80. A large score indicates a high level of anxiety, and a small score indicates a low level of anxiety.

    Before the intervention

  • Anxiety Level

    State-Trait Anxiety Inventory is a Likert-type scale consisting of 20 questions that measures state and trait anxiety levels separately. There are two kinds of expressions in the scales. These are called direct and reverse expressions. Direct expressions, negative emotions; reversed expressions express positive emotions. The scores obtained from both scales separately vary between 20 and 80. A large score indicates a high level of anxiety, and a small score indicates a low level of anxiety.

    After the 4-week intervention period.

  • Anxiety Level

    State-Trait Anxiety Inventory is a Likert-type scale consisting of 20 questions that measures state and trait anxiety levels separately. There are two kinds of expressions in the scales. These are called direct and reverse expressions. Direct expressions, negative emotions; reversed expressions express positive emotions. The scores obtained from both scales separately vary between 20 and 80. A large score indicates a high level of anxiety, and a small score indicates a low level of anxiety.

    After the 8-week intervention period.

  • Fasting blood glucose value

    Peripheral glucose values are recorded at the morning fasting. Mean fasting blood glucose is defined as \<95 mg/dL.

    Before the intervention

  • Fasting blood glucose value

    Peripheral glucose values are recorded at the morning fasting. Mean fasting blood glucose is defined as \<95 mg/dL.

    After the 4-week intervention period.

  • Fasting blood glucose value

    Peripheral glucose values are recorded at the morning fasting. Mean fasting blood glucose is defined as \<95 mg/dL.

    After the 8-week intervention period.

  • Postprandial 1 hour blood glucose value

    Peripheral glucose values are recorded at the morning 1 hour blood glucose. Mean 1 hour blood glucose is defined as \<140 mg/dL.

    Before the intervention

  • Postprandial 1 hour blood glucose value

    Peripheral glucose values are recorded at the morning 1 hour blood glucose. Mean 1 hour blood glucose is defined as \<140 mg/dL.

    After the 4-week intervention period.

  • Postprandial 1 hour blood glucose value

    Peripheral glucose values are recorded at the morning 1 hour blood glucose. Mean 1 hour blood glucose is defined as \<140 mg/dL.

    After the 8-week intervention period.

  • Postprandial 2 hour blood glucose value

    Peripheral glucose values are recorded at the morning 2 hour blood glucose. Mean 2 hour blood glucose is defined as \<120 mg/dL.

    Before the intervention

  • Postprandial 2 hour blood glucose value

    Peripheral glucose values are recorded at the morning 2 hour blood glucose. Mean 2 hour blood glucose is defined as \<120 mg/dL.

    After the 4-week intervention period.

  • Postprandial 2 hour blood glucose value

    Peripheral glucose values are recorded at the morning 2 hour blood glucose. Mean 2 hour blood glucose is defined as \<120 mg/dL.

    After the 8-week intervention period.

Secondary Outcomes (2)

  • Weekly physical activity level

    8 weeks

  • Level of compliance with the weekly diet

    8 weeks

Study Arms (2)

İntervention group

EXPERIMENTAL

Progressive Muscle Relaxation Training Program; The training was carried out in a single session for 2 hours and a break of 10-15 minutes was given. Pregnant women were instructed to perform PMR at least 1 hour after dinner 5 days a week.

Behavioral: Diet therapy, Progressive Muscle Relaxation training, Progressive Muscle Relaxation group

Control group

ACTIVE COMPARATOR

The Progressive Muscle Relaxation Training Program and the Progressive Muscle Relaxation were not applied. The pregnant women were asked to continue their normal daily activities for 8 weeks.

Behavioral: The group who received diet therapy and practiced their daily activities.

Interventions

The group that received Progressive Muscle Relaxation training and applied progressive muscle relaxation for 8 weeks.

İntervention group

The group who received diet therapy and practiced their daily activities.

Control group

Eligibility Criteria

Age19 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • At least 24 weeks of pregnancy,
  • years old (fertility period),
  • no history of diabetes before pregnancy,
  • First time diagnosed with GDM,
  • Body Mass Index (BMI) at a normal level of 18.5-24.9
  • Receiving information about diabetes nutrition during pregnancy from the SBUAEAH Diet Polyclinic.
  • Those who do not actively participate in birth preparation classes
  • Literate,
  • Do not have any barriers to prevent communication (hearing, hearing impairment, etc., use of languages other than Turkish),
  • Residing in Antalya city center
  • Agreeing to blood glucose measurements by the researcher
  • Not using complementary therapies based on mind-body techniques such as acupuncture and massage during the research.

You may not qualify if:

  • Having multiple pregnancies
  • Having a diagnosed disease other than GDM (polyhydramnios, multiple pregnancy, pregnancy-induced hypertension, cardiac problems)
  • It consisted of women who did not accept to participate in the research.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Akdeniz Üniversitesi Hemşirelik Fakültesi

Konyaalti, Antalya, 07050, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Diabetes, GestationalAnxiety Disorders

Interventions

Diet Therapy

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesMental Disorders

Intervention Hierarchy (Ancestors)

Nutrition TherapyTherapeutics

Study Officials

  • Nilüfer Tok Yanık

    Ege Üniversitesi Hemşirelik Fakültesi

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Using a computer program, the researchers randomly placed pregnant women who received dietary advice into either the intervention group or the control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

September 12, 2022

First Posted

November 10, 2022

Study Start

October 1, 2018

Primary Completion

October 30, 2020

Study Completion

September 30, 2021

Last Updated

November 10, 2022

Record last verified: 2022-11

Locations